Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-06

Clinical Trial Update: Diindolylmethane in Treating Patients With Breast Cancer [NA]

View source ↗

Summary

A University of Arizona–sponsored clinical trial evaluating diindolylmethane in breast cancer patients has completed, enrolling patients across multiple stages …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diindolylmethane (diindolylmethane)

Snippet

Sponsor: University of Arizona | Conditions: Stage IA Breast Cancer, Stage IB Breast Cancer | NA | Status: COMPLETED